Aberdeen
VC Fund
Edinburgh, United Kingdom
Aberdeen is a VC fund in Edinburgh focused on Financial Services and Biotechnology. Abrdn enables its clients to plan, save, and invest for their futures. Abrdn is operating across three vectors that reflect how their clients interact with them. Abrdn has the full ecosystem of capabilities to enable our clients to be better investors.
- Total investments:
- 19
- Last investment:
- Lead investor:
- 26%
- Last fund:
Last updated:
For AI agents: llms.txt
Industries Aberdeen invests in
Stages Aberdeen invests in
Countries Aberdeen invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alan R. Goodson
|
|||
Barry Fricke
|
|||
Gershon Cohen
|
|||
James Hathway
|
|||
Jonathan Asquith
|
|||
| See all 10 contacts → | |||
Investment Focus
Industry
- Financial Services 5 (26%)
- Biotechnology 4 (21%)
- Software 3 (16%)
- FinTech 2 (11%)
- Medical 2 (11%)
Stage
- Series B 4 (21%)
- Private Equity 4 (21%)
- Series A 3 (16%)
- Funding Round 2 (11%)
- Post-IPO Debt 1 (5%)
Country
- United States 6 (32%)
- United Kingdom 6 (32%)
- India 1 (5%)
- Canada 1 (5%)
- Finland 1 (5%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Alan R. Goodson
Head of Product & Client Solutions - Americas
|
Head of Product & Client Solutions - Americas | Total investments: 0 | Find email | |
|
Barry Fricke
Private Markets - Global Head of Product, Investment Specialists & Client Solutions
|
Private Markets - Global Head of Product, Investment Specialists & Client Solutions | Total investments: 0 | Find email | |
|
Gershon Cohen
Global Head of Infrastructure Funds
|
Global Head of Infrastructure Funds | Total investments: 0 | Find email | |
|
James Hathway
Enterprise Architect
|
Enterprise Architect | Total investments: 0 | Find email | |
|
Jonathan Asquith
Senior Independent Director
|
Senior Independent Director | Total investments: 0 | Find email | |
| See all 10 team members → | ||||
Investments
| Company | Description | Round | Links |
|---|---|---|---|
FNZ
|
FNZ is a FinTech firm that partners with financial institutions to enable them to provide multi-channel wealth management services to their clients across direct, intermediated, and workplace channels. FNZ develops long-term partnerships with customers to enable them to get to market with a market-leading digital proposition, transform theircustomer service offering, and grow assets under management across multiple distribution channels. | $650M / Private Equity / Nov 12, 2025 | |
Atalanta Therapeutics
|
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases by utilizing its proprietary RNA interference platform. | $97M / Series B / Jan 28, 2025 | |
Radiant Biotherapeutics
|
Radiant Biotherapeutics is a revolutionary antibody platform company leading the new frontier of multi-valent, multi-specific therapeutics to deliver transformative therapies for patients. | $35M / Series A / Sep 11, 2024 | |
Qlaris Bio
|
Qlaris Bio focuses on developing novel and innovative therapies for serious and debilitating ophthalmic diseases. Qlaris Bio is a spinout company of Qrativ, a biotechnology incubator formed as a joint venture between Mayo Clinic and inference, a pharmaceutical-focused artificial intelligence company. Its lead program is QLS-101, a novel compoundinvented at Mayo Clinic and the University of Minnesota. QLS-101, with its unique and first-in-class mechanism of action, may potentially serve as an efficacious treatment for high unmet need conditions related to disturbances in intraocular pressure, including a sight-threatening and progressive Pediatric Rare Disease for which effective therapies remain elusive and limited.Qlaris Bio was founded in 2019 and is headquartered in Cambridge, Massachusetts. | $24M / Series B / Apr 22, 2024 | |
Sammaan Capital
|
Sammaan Capital offers loans such as home loans, home loans for NRIs, and loans against properties at affordable interest rates for salaried and self-employed individuals within a shorter period. The company is based in India and it was founded in 2000. | $347.9M / Post-IPO Debt / Mar 27, 2024 | |
Engrail Therapeutics
|
Engrail is forging a new direction to reduce the enormous burden of diseases that impact the nervous system. We unite biological insights with clinically meaningful solutions to build and catalyze a diversified portfolio of transformative medicines. Harnessing our rigorous scientific approach to identify the most promising therapies, we leverageour flexible transaction model to advance assets with validated mechanisms and efficiently move them through development to commercialization. | $157M / Series B / Mar 19, 2024 | |
Etelä-Savon Energia
|
Etelä-Savon Energia produces light,heat and energy savings. | Private Equity / Nov 06, 2023 | |
|
Etelä-Savon Energia
|
Etelä-Savon Energia produces light,heat and energy savings. | Private Equity / Nov 06, 2023 | |
Eagle Genomics
|
Eagle Genomics is a enterprise software solutions company whose products enable the management, orchestration and exploitation of genomics and other life sciences data. They help Life Science companies get the maximum value from their R&D data and they are delivering the information architecture for the genomics era. Their suite of softwareproducts radically reduces cost and time to complete research, enabling drastic productivity improvements.Their architecture translates data sets into data assets, redefining the current paradigm in the industry, enabling the objective measurement of the value of digital assets and providing clarity on “return on information”. Their mix of expertise in biology, bioinformatics, data science and enterprise-class software engineering is unique in the field and has been applied over the last decade to solve their customers’ challenges in areas as diverse as drug development, personal hygiene and plant breeding.With global customers in the pharmaceuticals, fast moving consumer goods and agri-tech industries they understand the common challenges facing these industries in the handling of ever growing of data and information resources. Eagle Genomics is at the forefront in addressing the challenges, risks, and opportunities in delivering the enterprise information architecture for the genomics era. | $3.6M / Venture - Series Unknown / Sep 27, 2023 | |
Trinity Gas Storage
|
Trinity Gas Storage offers tailored gas storage services to meet the needs of a wide range of potential gas storage customers. | Private Equity / Sep 11, 2023 | |
| See all 19 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Aberdeen invest in?
Aberdeen invests primarily in Financial Services, Biotechnology and Software startups, most often at Series B and Private Equity stage. Most of the 19 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Aberdeen?
Public channels for Aberdeen include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Aberdeen?
The team at Aberdeen includes Alan R. Goodson (Head of Product & Client Solutions - Americas), Barry Fricke (Private Markets - Global Head of Product, Investment Specialists & Client Solutions) and Gershon Cohen (Global Head of Infrastructure Funds), among 10 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
